Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Pushing back against Eli Lilly motion, federal judge sends years-long whistleblower case to trial
4 years ago
Law
Roche steps up with a free supply of antibiotics for Ukraine as drug donations begin to flow
4 years ago
Horizon cooks up new rare disease awareness campaign with blind MasterChef Christine Ha
4 years ago
Marketing
Biden continues his pledge for Medicare drug price negotiations in State of the Union speech
4 years ago
Coronavirus
Bayer rushes support to Ukraine staff, helping with cash and housing as Russians attack major cities
4 years ago
Bioregnum
How Operation Warp Speed clashed with Pfizer in the early days of the pandemic
4 years ago
Coronavirus
Novavax doubles down on promise to produce 2B Nuvaxovid doses — this year
4 years ago
R&D
Manufacturing
CureVac establishes RNA printer-specific company as light at the end of tunnel nears
4 years ago
Manufacturing
MarketingRx roundup: Rare disease day efforts from Pfizer, Horizon and more; J&J reboots online MG campaign
4 years ago
Marketing
MarketingRx Matchup: Is it Novo Nordisk’s Ozempic or Lilly and BI’s Jardiance for the win in Type 2 ads?
4 years ago
Marketing
'We are ready to go': FDA OKs J&J and Legend's BCMA CAR-T, setting stage for showdown with Bristol Myers
4 years ago
FDA+
GlaxoSmithKline consumer business Haleon lays out game plan after July spinout
4 years ago
Viatris agrees to pay $264M to settle EpiPen class action case
4 years ago
Law
Pharmas rally to protect employees in Ukraine, along with support and donations to Russia-invaded country
4 years ago
Marketing
Pfizer and Alvotech look to interchangeability to stand out in a crowded Humira biosimilar field
4 years ago
J&J grows investment fund for entrepreneurs, sets 2022 focus on healthcare worker gaps and racial inequities
4 years ago
Marketing
Emergent's troubled Baltimore site gets $100M upgrade
4 years ago
Manufacturing
Safety concerns cause GSK to stop highly anticipated vaccine trial in surprise setback
4 years ago
R&D
Developers of a key mRNA delivery tech, seeking a piece of Moderna's Covid riches, sue for patent infringement
4 years ago
Law
FDA rejects Reata's kidney drug after adcomm voted unanimously against it
4 years ago
FDA+
US judge rules in favor of J&J in controversial 'Texas two-step' case
4 years ago
EMA shortens timeline for Moderna's Spikevax Covid booster
4 years ago
Coronavirus
Biohaven continues push for oral migraine med Nurtec amid new portfolio line up
4 years ago
Marketing
FTC wants to know: How are PBMs affecting drug affordability and access?
4 years ago
First page
Previous page
219
220
221
222
223
224
225
Next page
Last page